DUBLIN , Oct. 11, 2022 /PRNewswire/ -- The "Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), by Region (MEA, EU, North America , APAC), and Segment Forecasts, 2022-2030" report has been added to  ResearchAndMarkets.com's offering.

The global hyaluronic acid market size is expected to reach USD 16.8 billion by 2030, expanding at a CAGR of 7.45%, according to this report. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers.

The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. The increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with the growing awareness about anti-aging products is fueling the growth. The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal."

As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in the inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect." Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia , and Japan . North America held the maximum revenue share in 2021. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2021, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period. The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. The rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany . The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector Hyaluronic Acid Market Report Highlights

The osteoarthritis segment dominated the global industry and accounted for the maximum share of the overall revenue in 2021

The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as a treatment

Hyaluronic acid acts as a shock absorber or a cushion and lubricates the joints, thus helping in proper functioning

There are a number of ophthalmic surgical products that use hyaluronan/hyaluronic acid as an active ingredient

These include Vitrax, Healon, Amivisc Plus, Amvisc, Hylan G-F20, and Opegan

The increasing prevalence of age-related eye diseases, dry eye syndrome, adult-vision impairments, and chronic diseases, such as diabetes, are major factors leading to segment growth

Growing Awareness for Antiaging Products

High Prevalence of Target Diseases

Associated Adverse Effects of Hyaluronic Acid

High Cost of Products and Related Services

Key Topics Covered: Chapter 1 Methodology and Scope Chapter 2 Executive Summary Chapter 3 Market Variables, Trends, & Scope Chapter 4 Hyaluronic Acid Market: Application Analysis Chapter 5 Hyaluronic Acid Market: Regional Analysis Chapter 6 Reimbursement Outlook Chapter 7 Competitive Analysis Companies Mentioned

Lg Life Sciences Ltd (Lg Chem.)

For more information about this report visit https://www.researchandmarkets.com/r/yidje8

Research and Markets  Laura Wood , Senior Manager  press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470  For U.S./CAN Toll Free Call +1-800-526-8630  For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907  Fax (outside U.S.): +353-1-481-1716

Logo: http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/hyaluronic-acid-global-market-report-2022-desire-for-quick-and-evident-results-boosting-demand--growth-301645677.html

Billionaire hedge-fund investor Paul Tudor Jones says investors looking to time the bottom in stocks should keep a close eye on short-term Treasury yields.

After the annus horribilis of 2022, with the final quarter now in play, investors will be hoping a late-year rally will materialize. According to Carson Group's chief market strategist Ryan Detrick, that’s not such a far-fetched idea. "While October has a reputation for crashes, it is really a bear market killer,” Detrick recently wrote. “Of the past 17 bear (or near bear markets), stocks bottomed in October six times. Could it happen again? With sentiment this pessimistic and extremely positive

The market hammered shares of these stocks into the dirt this year, but some of the world's most successful investors kept on buying.

Yahoo Finance's Alexandra Semenova breaks down what to watch from big banks as they're set to release earnings this week.

You have just a few weeks to pounce on Treasury I bonds' sky-high interest rate. Also called Series I savings bonds, their interest rate is 9.62%.

Cannabis could be one of the fastest-growing industries of the decade, but not all weed stocks will be winners.

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Anyone who held Carnival Corporation...

Shares of enterprise software companies Twilio (NYSE: TWLO), Snowflake (NYSE: SNOW), and Appian (NASDAQ: APPN) fell hard again Monday, down 6.3%, 9.3%, and 6.5%, respectively, as of 3:44 p.m. EDT. In addition, long-term bond yields remained high. On Monday, cloud-based service-center software company Five9 (NASDAQ: FIVN) plunged over 25%, after CEO Rowan Trollope announced he would be resigning for another role at a pre-IPO tech company.

The sour mood came as UK unemployment tumbled unexpectedly to its lowest since 1974 as people dropped out of the workforce at a record rate.

Many hyper-growth stocks skyrocketed to all-time highs last year as overly bullish investors convinced themselves it was reasonable to pay 30, 40, or even 50 times sales for unprofitable tech companies. Let's take a look at three promising hyper-growth stocks that investors should consider buying today before the bulls come back: Snowflake (NYSE: SNOW), CrowdStrike (NASDAQ: CRWD), and Cloudflare (NYSE: NET).

In this article, we discuss 5 dividend stocks that are too cheap to ignore. You can skip our detailed analysis of dividend stocks and their returns in the past, and go directly to read 5 Dividend Stocks That Are Too Cheap To Ignore. As the market plunges to its new lows in 2022, investors are […]

A Cowen analyst says chip stocks are near all-time low valuations after their big drops this year. Several offer solid buying opportunities.

Vox Royalty Corp. (TSXV: VOX) (NASDAQ: VOXR) ("Vox" or the "Company"), a returns focused mining royalty company, is pleased to announce that its common shares will commence trading on The Nasdaq Stock Market ("Nasdaq") at market open today under the ticker symbol "VOXR". Vox's common shares will continue to trade on the TSX Venture Exchange under the ticker symbol "VOX".

(Bloomberg) -- Wall Street is bracing for a rough earnings season as macroeconomic issues weigh on profit margins. But even if third-quarter results aren’t so bad, the bigger fear is what Corporate America sees on the horizon.Most Read from BloombergHere’s How Weird Things Are Getting in the Housing MarketScreening Procedure Fails to Prevent Colon Cancer Deaths in Large StudyPutin Threatens More Missile Attacks on Ukraine as Cities HitThis Is What 7% Mortgages Will Do to the Housing Market‘No Po

It's looking like a rough day for stocks. Our call of the day is a look at the future and a billion-dollar industry and some stocks to play it, from Citigroup.

Verizon Communications (VZ) closed at $36.62 in the latest trading session, marking a -0.62% move from the prior day.

The S&P 500, the Dow Jones Industrial Average, and the Nasdaq Composite are all in bear market territory, trading down over 20% from their highs. The brutal sell-off weighed heavily on tech stocks like Roblox (NYSE: RBLX) and Skyworks Solutions (NASDAQ: SWKS). Roblox stock has lost two-thirds of its value so far in 2022.

Shares of Ford Motor Co. were hit hard Monday by UBS analyst Patrick Hummel's recommendation that investors sell, as the auto industry is facing a worrisome U-turn from undersupply to oversupply.

The S&P 500 last peaked in early January, and the broad-based index has since lost 24% of its value, putting it in a bear market. For instance, Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Okta (NASDAQ: OKTA) both have a consensus rating of buy among analysts right now. Better yet, Tigress Financial analyst Ivan Feinseth has a price target of $186 per share on Alphabet, which implies 87% upside.

Today we're going to take a look at the well-established Broadcom Inc. ( NASDAQ:AVGO ). The company's stock saw...